You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoblast Cell Lines

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral Blood Stem Cell Transplantation Trial in Beijing (Modified By/Cy conditioning regimen intensified by Ruxolitinib and

Recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Modified By/Cy conditioning regimen intensified by Ruxolitinib and Chidamide
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 12, 2021

Small Cell Lung Cancer Trial (Tarlatamab)

Available
  • Small Cell Lung Cancer
  • (no location specified)
Sep 26, 2023

Learn About First and Later Lines of Medicines in Treating

Completed
  • Metastatic Renal Cell Carcinoma
    • New York, New York
      Pfizer Headquarters
    May 12, 2023

    B-Cell Acute Lymphoblastic Leukemia, Adult Trial in La Jolla, Orange, San Francisco (blinatumomab, pembrolizumab)

    Terminated
    • B-Cell Acute Lymphoblastic Leukemia, Adult
    • La Jolla, California
    • +2 more
    Apr 26, 2022

    Peripheral Blood Stem Cell Transplantation Trial in Beijing (Ruxolitinib combined with Chidamide.)

    Recruiting
    • Peripheral Blood Stem Cell Transplantation
    • Ruxolitinib combined with Chidamide.
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Oct 20, 2021

    Fibroblast-Derived Cell Lines From Skin Biopsies of

    Enrolling by invitation
    • Primary Immunodeficiency
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 18, 2023

      Healthy Participants Trial in Daytona Beach, Madison (Eptinezumab Mammalian Cell Line, Eptinezumab Yeast Cell Line)

      Completed
      • Healthy Participants
      • Eptinezumab Mammalian Cell Line
      • Eptinezumab Yeast Cell Line
      • Daytona Beach, Florida
      • +1 more
      Aug 25, 2022

      Viral Infections After HSCT Trial in Washington (VSTs)

      Active, not recruiting
      • Viral Infections After HSCT
      • VSTs
      • Washington, District of Columbia
        Childrens National Medical Center
      Aug 30, 2022

      Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

      Recruiting
      • Epstein-Barr Virus Infections
      • +2 more
      • Group A
      • Group B
      • Montreal, Quebec, Canada
        Hôpital Maisonneuve-Rosemont
      Apr 5, 2022

      Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

      Recruiting
      • Adenovirus Infection
      • +6 more
      • Virus-specific Cytotoxic T-lymphocytes
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 6, 2023

      Periodontal Attachment Loss Trial in Bengaluru (extracorporeal shockwave device, Fibroblast cell lines not subjected to

      Completed
      • Periodontal Attachment Loss
      • extracorporeal shockwave device
      • Fibroblast cell lines not subjected to shockwaves from extracorporeal shockwave device
      • Bengaluru, Karnataka, India
        Krishnadevaraya College of Dental Science and Hospital
      Mar 2, 2023

      Cell Collection to Study Eye Diseases

      Recruiting
      • Retinal Disease
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 23, 2023

        Stem Cells in NF1 Tumors of the Central Nervous System

        Suspended
        • Neurofibromatosis Type 1
        • Tumors of the Central Nervous System
        • Collection of Stem Cells
        • Washington, District of Columbia
          Children's National Medical Center
        Mar 8, 2022

        Explanted Lung Tissues With Pulmonary Fibrosis

        Recruiting
        • Pulmonary Fibrosis
          • Chicago, Illinois
            The University of Chicago
          Nov 18, 2022

          Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

          Recruiting
          • Small Cell Lung Cancer
          • Beijing, Beijing, China
            Cancer Hospital, Chinese Academy of Medical Sciences
          May 4, 2022

          Utility of Primary Glioblastoma Cell Lines

          Recruiting
          • Tumor
          • Brain Tumor
            • Pozzilli, IS, Italy
              Neuromed IRCCS
            Apr 9, 2021

            Multiple Myeloma in Relapse Trial in Finland, Sweden (Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone)

            Active, not recruiting
            • Multiple Myeloma in Relapse
            • Carfilzomib for Inj 60 milligram (MG)
            • +2 more
            • Helsinki, Finland
            • +7 more
            Mar 14, 2022

            Models in Neuroendocrine Neoplasm

            Recruiting
            • Neuroendocrine Neoplasm
            • Biopsy, open or laparoscopic surgery
            • Shanghai, Shanghai, China
              Department of Pancreatic Surgery, Fudan University Shanghai Canc
            Sep 19, 2021

            Carcinoma, Non-small Cell Lung Trial in Changsha (ethaselen)

            Completed
            • Carcinoma, Non-small Cell Lung
            • Changsha, Hunan, China
              Hunan province tumor hospital
            Mar 1, 2022

            Multiple Myeloma Trial (Pembrolizumab)

            Withdrawn
            • Multiple Myeloma
            • (no location specified)
            Apr 20, 2022

            Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

            Recruiting
            • Recurrent Plasma Cell Myeloma
            • Refractory Plasma Cell Myeloma
            • Des Moines, Iowa
            • +8 more
            Jan 12, 2023

            NSCLC (NSCLC) Trial in China (Capmatinib)

            Recruiting
            • Non-Small Cell Lung Cancer (NSCLC)
            • Xiamen, Fujian, China
            • +18 more
            Jan 27, 2023

            Generation of Antigen-specific T-lymphocyte Cell Lines From

            Terminated
            • Healthy
            • Leukapheresis
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Feb 2, 2021

            Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in China, Taiwan (TJ202 and Dexamethasone)

            Active, not recruiting
            • Multiple Myeloma in Relapse
            • Refractory Multiple Myeloma
            • TJ202 and Dexamethasone
            • Beijing, Beijing, China
            • +17 more
            Oct 17, 2022

            T-cell Acute Lymphoblastic Leukemia Trial in Chicago (Daratumumab / Hyaluronidase Injection)

            Recruiting
            • T-cell Acute Lymphoblastic Leukemia
            • Daratumumab / Hyaluronidase Injection
            • Chicago, Illinois
              Northwestern
            Jun 17, 2022